BASF Faces Twin Tests: Passing On Costs in Asia While Losing Buyback Cushion
06.06.2026 - 03:35:00 | boerse-global.de
The German chemicals heavyweight is navigating a delicate balancing act. As its €1.5 billion share buyback programme approaches the finishing line at the end of June, BASF has fired a price hike signal in the Asia-Pacific region for butyl acrylate, trying to offset rising input costs. The twin developments underscore how the company must now rely more on operational performance than financial engineering to support its stock.
The price increase for butyl acrylate — a key ingredient in adhesives, paints and construction chemicals — amounts to up to $100 per tonne, effective immediately or as existing contracts allow. BASF cites higher raw material and production input costs. But the move is limited to the Asia-Pacific region and does not necessarily signal broader pricing power across the group. The petrochemicals segment, which houses the product, generated third-party sales of around €7.5 billion in 2025.
The timing of the price action is notable given the wider industry headwinds. Germany’s chemical industry association VCI expects stagnating production in the chemical-pharmaceutical sector for 2026, with chemical output alone forecast to decline 1 per cent. Combined with falling prices, that would translate into a 3.5 per cent revenue drop. In the first quarter, BASF’s production fell 2.8 per cent seasonally adjusted from the previous quarter and was nearly 6 per cent lower year-on-year. Capacity utilisation stayed stuck at 75.1 per cent.
Against that backdrop, the buyback programme has been a visible support for the shares. Launched in November 2025 with a maximum volume of €1.5 billion, it is set to conclude by the end of this month. As of June 1, BASF had bought back 27,835,549 shares, including 950,000 on that same day, all destined for cancellation. The reduction in outstanding shares has flattered earnings per share, which rose to €1.06 in the first quarter from €0.91 a year earlier, even as EBITDA before special items slipped to around €2.4 billion.
Should investors sell immediately? Or is it worth buying BASF?
Once the repurchases stop, that technical tailwind disappears. Not that selling pressure will automatically follow — but the operating business will have to carry more of the weight. The larger capital-return framework announced at the Capital Markets Day in September 2024 remains in place: at least €12 billion in total shareholder distributions by 2028, with roughly €8 billion earmarked for dividends and €4 billion for buybacks. The current programme is merely the first tranche.
To improve its industrial earnings power, BASF is pushing ahead with its CoreShift cost-cutting initiative, which targets a 20 per cent reduction in fixed costs by 2029 compared with the 2024 baseline. The programme covers the Chemicals, Materials, Industrial Solutions and Nutrition & Care divisions — the heart of the company’s commodity and specialty portfolio. The urgency is most visible at the Ludwigshafen site, which posted its fourth consecutive annual loss and has shed roughly 2,800 jobs since the start of 2024.
The first-quarter results already laid bare the strains. Revenue fell to €16.0 billion from €16.5 billion a year earlier, weighed down by negative currency effects from the US dollar and Chinese renminbi, as well as price pressure across several segments. EBITDA before special items declined to €2.36 billion. Management has nevertheless maintained its full-year guidance for EBITDA before special items of €6.2 billion to €7.0 billion and free cash flow of €1.5 billion to €2.3 billion.
BASF at a turning point? This analysis reveals what investors need to know now.
Shares recently changed hands at €50.83, up 0.51 per cent on the day and 13.61 per cent since the start of the year — but still roughly 8 per cent below the April high of €55.05. The stock sits below its 50-day moving average of €52.41, though comfortably above the 200-day average of €46.82. All eyes now turn to the conference call on July 29, when the half-year report will reveal whether price moves like the butyl acrylate hike can begin to stabilise margins in the petrochemical division — just as the buyback safety net vanishes.
Ad
BASF Stock: New Analysis - 6 June
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis BASF Aktien ein!
FĂĽr. Immer. Kostenlos.
